PHARMAQ AS
Head office/
Production facility
Skogmo Industriområde
Industrivegen 50
N-7863 Overhalla, Norway
Tel:+47 74 28 08 00
customer.service@pharmaq.no
PHARMAQ AS
Production facility
Dyrskuevien 13, 2040 Kløfta
P.O.Box 152, N-2041 Kløfta, Norway
Tel: +47 23 29 85 00
customer.service@pharmaq.no
PHARMAQ ACHIEVEMENTS
1987

We launched the first vaccine ever against cold water vibriosis - ”saving” the Norwegian salmon industry and dramatically reduced the use of antibiotics
1991

Introduction of the world’s first oil based fish vaccine offering protection against furunculosis
1996

Our State-of-the-art GMP production facility for fish vaccines opens in Overhalla, Norway
1997

The first six component vaccine ever introduced in Norway. Includes protection against IPNV and winter ulcer.
1998

ALPHA MAX® for bath treatment against salmon lice available in the Norwegian- and the Faroese market
2001

Established office in Puerto Montt, Chile, later to become PHARMAQ AS Chile Ltda.
2002

The first European fish vaccine ever approved by the Canadian authorities
2004

Obtained approval in UK for the first virus vaccine for fish - protection against IPNV and furunculosis
2004

PHARMAQ established 23 July by 'management buy out' of the Aquatic Animal Health business of Alpharma Inc.
2007

Launch of our first generation SRS vaccine in Chile
2008

MA approved for ALPHA JECT micro® 6 in Norway, the first six-component micro dose vaccine available
2008

Sales license for ALPHA JECT® micro 3 in Chile, the first trivalent SRS micro dose vaccine available
2008

PHARMAQ opened office in Vietnam, later to become PHARMAQ Ltd. VN
2008

Acquisition of PHARMAQ by Orkla and Kverva
2009

Extensive field trial of the first Pangasius vaccine started in Vietnam
2010

PHARMAQ’s first ISA vaccine received a provisional marketing authorisation from the Chilean authorities
2011

PHARMAQ officially opened its PHARMAQ Turkey Ltd office in Izmir in May
2011

PHARMAQ signed a long term agreement with Norwegian Institute of Public Health for lease of virus antigen production facilities in Norway
2011

As the first fish vaccine commercially available in Vietnam, ALPHA JECT Panga 1 received a observation license
2012

PHARMAQ Holding acquires Havbruksinstituttet AS, renamed as PHARMAQ Analytiq
2013

Permira acquired PHARMAQ May 2013
2014

PHARMAQ and The Ministry of Agriculture and Rural Development in Vietnam signed agreement of co-operation
2015

PHARMAQ is now part of Zoetis, the world leader in animal health. For more information about our owner, visit www.zoetis.com
2016

PHARMAQ launched our first attenuated live vaccine in Chile against SRS, ALPHA JECT LiVac® SRS
2017

PHARMAQ acquires Nordland Settvaks and Norway Fishtech, renamed as PHARMAQ Settvac and PHARMAQ Fishteq
Future

We make aquaculture progress!